Dutch Insurance Stock News

ENXTAM:KPN
ENXTAM:KPNTelecom

Does Twilio–Google RCS Partnership Make KPN the Backbone of Dutch Business Messaging (ENXTAM:KPN)?

At Mobile World Congress in March 2026, Twilio announced a partnership with KPN Netherlands and Google to roll out nationwide Rich Communication Services (RCS) Business Messaging across all major Dutch mobile operators, with Android support at launch and broader device coverage expected in 2026. This collaboration places KPN at the core of the Netherlands’ business messaging infrastructure, enabling enterprises to use richer, measurable and verified communications within native messaging...
ENXTAM:HEIA
ENXTAM:HEIABeverage

Is Legal Setbacks And Zero-Calorie 0.0 Ultimate Altering The Investment Case For Heineken (ENXTAM:HEIA)?

In February 2026, the Amsterdam District Court issued an interim judgment in Macedonian Thrace Brewery’s long-running damages case against Heineken and Athenian Brewery, accepting MTB’s expert model and indicating principal damages of at least €43.00 million, with total awards including interest expected to exceed €83.00 million once finalized. Around the same time, Heineken advanced its push into non-alcoholic beer with the launch of Heineken 0.0 Ultimate in select U.S. states, introducing...
ENXTAM:PRX
ENXTAM:PRXMultiline Retail

Prosus (ENXTAM:PRX) Valuation Check After Tencent-Led Share Price Rebound On Iran De‑Escalation Hopes

Prosus (ENXTAM:PRX) jumped in early European trading after a sharp move higher in Tencent Holdings, as investors reacted to a U.S. presidential statement that hinted at possible easing of tensions in the Iran conflict. See our latest analysis for Prosus. Beyond today’s reaction to Tencent, Prosus has a 7.6% 1 year total shareholder return and a 57.8% 3 year total shareholder return, despite a 13.4% year to date share price decline. This suggests recent momentum has been rebuilding after a...
ENXTAM:AALB
ENXTAM:AALBMachinery

Is Aalberts (ENXTAM:AALB) Share Price Weakness Creating A Long Term Opportunity?

If you are wondering whether Aalberts is fairly priced or offering value at its recent share price, this article will walk through what the numbers actually say rather than relying on headlines or hype. The stock last closed at €31.76, with a 7 day return of a 4.5% decline, a 30 day return of a 9.8% decline, a year to date return of 11.4%, and a 1 year return of a 2.5% decline. Taken together, this gives you a mixed picture of recent momentum and shifting risk appetite. Recent coverage has...
ENXTAM:WHA
ENXTAM:WHARetail REITs

Wereldhave (ENXTAM:WHA) Valuation Check After Strong Multi Year Shareholder Returns

How Wereldhave’s recent share performance frames the current valuation debate Wereldhave (ENXTAM:WHA) has drawn attention after a year total return of 45.7%, alongside a past 3 months gain of 12.1%, even as the share price has seen a 3% decline over the past month. For investors tracking consistency rather than short term price moves, the 3 year total return of 89.3% and 5 year total return of 105.1% sit against current annual revenue of €215.859m and net income of €73.344m. See our latest...
ENXTAM:INGA
ENXTAM:INGABanks

Is ING Groep (ENXTAM:INGA) Still Attractive After Strong Multi Year Share Price Gains

If you are wondering whether ING Groep is attractively priced today or getting ahead of itself, you are not alone. This article is designed to walk you through that question step by step. The share price recently closed at €22.50, with a 1 year return of 29.7% and a very large 5 year return of around 2x. This comes even though the stock has seen a 0.8% decline over the last week, an 11.3% decline over the last month and an 8.1% decline year to date. Recent market attention has focused on ING...
ENXTAM:WKL
ENXTAM:WKLProfessional Services

Assessing Wolters Kluwer (ENXTAM:WKL) Valuation As 2025 Annual Report Highlights Expanded AI Focus

AI focus, product recognition and buybacks put Wolters Kluwer (ENXTAM:WKL) in the spotlight Wolters Kluwer (ENXTAM:WKL) has moved into focus after its 2025 Annual Report detailed an AI-focused plan across business lines, paired with fresh product milestones and an active €500 million share buyback program. See our latest analysis for Wolters Kluwer. Despite a recent 30 day share price return of 7.89%, Wolters Kluwer’s share price return is still down 23.53% year to date and its 1 year total...
ENXTAM:ASML
ENXTAM:ASMLSemiconductor

The Bull Case For ASML Holding (ENXTAM:ASML) Could Change Following Its Hybrid Bonding And Packaging Pivot

In recent months, ASML Holding has reinforced its EUV lithography leadership, secured continued reliance from major chipmakers, reported record bookings, and outlined new leadership appointments and capital return plans following its 2025 performance. At the same time, ASML is moving into advanced packaging and hybrid bonding tools while Chinese efforts to build rival EUV capabilities face substantial technological and supply chain hurdles. Now we will examine how ASML’s push into hybrid...
ENXTAM:PHIA
ENXTAM:PHIAMedical Equipment

Assessing Philips (ENXTAM:PHIA) Valuation After Recent Share Price Pullback

Recent performance snapshot Without a specific headline event driving attention today, Koninklijke Philips (ENXTAM:PHIA) may still interest you if you are tracking healthcare names with mixed short term and longer term return profiles. The stock shows a 0.9% decline over the past day and a 2.0% decline over the past week, with a larger 8.4% drop over the past month, while the past 3 months reflect a 7.3% gain. See our latest analysis for Koninklijke Philips. At a share price of €24.41, the...
ENXTAM:CVC
ENXTAM:CVCCapital Markets

A Look At CVC Capital Partners (ENXTAM:CVC) Valuation After 2025 Results And Performance Fee Guidance Reset

CVC Capital Partners (ENXTAM:CVC) is back in focus after its 2025 earnings release, where record realisations and profit met a sharp reset in performance fee guidance that weighed on investor sentiment. See our latest analysis for CVC Capital Partners. The share price reaction around the 2025 results sits within a tougher year overall, with a 90 day share price return of 21.89% and a 1 year total shareholder return decline of 40.23%, suggesting momentum has been fading despite ongoing...
ENXTAM:UMG
ENXTAM:UMGEntertainment

Universal Music Group (ENXTAM:UMG) Valuation Check After Dividend Proposal And 2025 Earnings Results

Universal Music Group (ENXTAM:UMG) drew investor focus after proposing a final dividend of €0.28 per share, alongside full year 2025 results that paired higher sales with lower net income versus the prior year. See our latest analysis for Universal Music Group. The latest dividend proposal and earnings update arrive after a weak run for the shares, with the latest share price at €18.16 and a 1 year total shareholder return decline of 27.24%, alongside a 3 year total shareholder return decline...
ENXTAM:ECMPA
ENXTAM:ECMPARetail REITs

Assessing Eurocommercial Properties (ENXTAM:ECMPA) Valuation After Recent Share Return Performance

What Eurocommercial Properties’ Recent Returns Say About Its Valuation With no single headline event driving attention today, Eurocommercial Properties (ENXTAM:ECMPA) is drawing interest because its recent share returns, valuation metrics and reported earnings profile present a compact snapshot for income and value oriented investors. See our latest analysis for Eurocommercial Properties. The current €26.4 share price sits against a 1-month share price return of 1.15% and a 90-day share price...
ENXTAM:SIFG
ENXTAM:SIFGElectrical

Sif Holding (ENXTAM:SIFG) Loss Worsens To €25.9 Million Challenging Bullish Turnaround Narratives

Sif Holding (ENXTAM:SIFG) has put fresh numbers on the table for FY 2025, with first half revenue of €258.2 million and a basic EPS loss of €0.91, setting a clear tone for where profitability currently stands. The company has seen revenue move from €230.98 million and EPS of €0.21 in the first half of 2024 to €198.0 million and an EPS loss of €0.36 in the second half of 2024, before landing at the latest half-year print. This keeps the focus firmly on how margins are holding up through this...
ENXTAM:DSFIR
ENXTAM:DSFIRChemicals

Assessing DSM-Firmenich (ENXTAM:DSFIR) After A 37% One-Year Share Price Slide

If you are wondering whether DSM-Firmenich at around €59 still reflects its true worth, you are not alone, and this article is built to help you assess what that price might really represent. The stock has been through a rough patch, with the share price down 14.6% over the last 30 days and 37.4% over the past year. It is up 2.9% over the past week and down 14.3% year to date. Recent coverage around DSM-Firmenich has focused on its position in the broader materials and specialty ingredients...
ENXTAM:FLOW
ENXTAM:FLOWCapital Markets

The Bull Case For Flow Traders (ENXTAM:FLOW) Could Change Following A US$12m Bitcoin Inflow To Its Desks

On 12 March 2026, around 180 BTC worth approximately US$12.07 million were transferred from several anonymous addresses to Flow Traders, underlining its operational role in cryptocurrency liquidity provision. This sizeable Bitcoin inflow brings fresh attention to how Flow Traders’ digital asset activity interacts with its broader multi-asset liquidity model. We’ll explore how this large Bitcoin transfer to Flow Traders could influence its investment narrative, especially regarding digital...
ENXTAM:IMCD
ENXTAM:IMCDTrade Distributors

Assessing IMCD (ENXTAM:IMCD) Valuation After Expanded Evonik Visiomer U.S. Distribution Deal

IMCD (ENXTAM:IMCD) is back on watch after Evonik Industries AG expanded its Visiomer specialty methacrylates distribution partnership into the U.S., giving IMCD added exposure to a key specialty chemicals segment. See our latest analysis for IMCD. The U.S. Visiomer deal and recent leadership changes sit against a mixed share price picture, with a 4.25% 1 day share price return and 2.49% 7 day share price return contrasting with a 21.31% 30 day share price decline and a 41.08% 1 year total...
ENXTAM:ARCAD
ENXTAM:ARCADProfessional Services

Assessing Arcadis (ENXTAM:ARCAD) Valuation After New Los Angeles Infrastructure Contracts

Event overview and why it matters Arcadis (ENXTAM:ARCAD) has secured two new contracts with the City of Los Angeles, covering work on the Los Angeles Convention Center Modernization and Expansion and the Department of Public Works Bureau of Engineering's Clean Water Program. The combined contract value exceeds €18 million, with €11 million tied to project and construction management support on the €2.5b convention center scheme and €7.5 million over five years for three stormwater initiatives...
ENXTAM:MT
ENXTAM:MTMetals and Mining

ArcelorMittal (ENXTAM:MT) Valuation Check After Recent Share Price Pullback And Cooling Momentum

ArcelorMittal (ENXTAM:MT) is back on investors’ radar after its recent share move, with the stock showing a mix of short term declines and longer term gains that invite a closer look. See our latest analysis for ArcelorMittal. That recent pullback, including a 4.22% one day share price decline and 11.43% 30 day share price return, sits against a stronger backdrop, with a 20.75% 90 day share price return and 66.18% one year total shareholder return. This suggests that earlier momentum is now...
ENXTAM:AALB
ENXTAM:AALBMachinery

Aalberts Reshapes Portfolio With BROEN Sale And €75m Buyback Plan

Aalberts has completed the divestment of BROEN A/S, advancing its ‘thrive 2030’ repositioning plan. The company is running a significant share buyback programme alongside the transaction. ENXTAM:AALB last closed at €32.78. For you as an ENXTAM:AALB watcher, these moves relate directly to how Aalberts is reshaping its portfolio and capital structure. The share price stands at €32.78, with a 14.9% gain year to date and a 3.5% return over 1 year, while 3 year and 5 year returns show declines...
ENXTAM:BFIT
ENXTAM:BFITHospitality

Basic Fit (ENXTAM:BFIT) Earnings Surge Tests Bullish High P/E Narrative

Basic-Fit (ENXTAM:BFIT) has wrapped up FY 2025 with second half revenue of €743.2 million and basic EPS of €0.34, alongside trailing 12 month revenue of €1.42 billion and basic EPS of €0.22. These figures frame the latest numbers in a broader earnings upswing. The company has seen revenue move from €630.44 million in the second half of 2024 to €743.2 million in the second half of 2025, while basic EPS shifted from €0.06 to €0.34 over the same periods. This sets up a story where higher sales...
ENXTAM:PHARM
ENXTAM:PHARMBiotechs

Pharming Group (ENXTAM:PHARM) Returns To Profitability Challenging Cautious Earnings Narratives

Pharming Group (ENXTAM:PHARM) has wrapped up FY 2025 with fourth quarter revenue of US$106.5 million and basic EPS of US$0.008, while trailing twelve month figures stand at US$376.1 million in revenue and basic EPS of US$0.004. This frames a year where profitability on a full year basis edges into positive territory. The company has seen quarterly revenue move from US$92.7 million in Q4 2024 and US$74.8 million in Q3 2024 to US$106.5 million in Q4 2025. Over the same period, quarterly basic...
ENXTAM:ENVI
ENXTAM:ENVIMachinery

Envipco Holding (ENXTAM:ENVI) Loss Of €10.8 Million Tests Bullish Profit Turnaround Narratives

Envipco Holding (ENXTAM:ENVI) has reported its FY 2025 results with fourth quarter revenue of €23.8 million and a basic EPS loss of €0.03, while trailing twelve month revenue stands at €90.4 million with a full year basic EPS loss of €0.18. Over recent quarters the company has seen revenue move between €21.0 million and €23.8 million per quarter, while quarterly basic EPS losses have ranged from €0.03 to €0.07. This sets the scene for a story where strong reported revenue growth meets...
ENXTAM:CVC
ENXTAM:CVCCapital Markets

CVC Capital Partners (ENXTAM:CVC) Margin Surge To 63.8% Tests Bullish Narratives

CVC Capital Partners (ENXTAM:CVC) has put up a punchy set of FY 2025 numbers, with first half revenue at €843.0 million and basic EPS of €0.54, set against trailing twelve month revenue of €1.85 billion and EPS of €1.11 that came with a very large year-on-year earnings increase and a net profit margin of 63.8% versus 14.4% the prior year. Over the past three reported halves, revenue has moved from €635.7 million with EPS of €0.05 in 1H 2024 to €926.2 million and EPS of €0.17 in 2H 2024,...
ENXTAM:DSFIR
ENXTAM:DSFIRChemicals

Assessing DSM-Firmenich (ENXTAM:DSFIR) Valuation After Prolonged Share Price Weakness

Recent share performance puts DSM-Firmenich in focus DSM-Firmenich (ENXTAM:DSFIR) has come onto investors’ radar after a series of weak returns, including an 18% decline over the past 3 months and a 41% negative total return over the past year. See our latest analysis for DSM-Firmenich. The recent weakness has been fairly persistent, with a 1-day share price return of a 1.91% decline and a 30-day share price return of a 17.06% decline adding to a 1-year total shareholder return of a 40.69%...